BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1700
+0.0014 (0.83%)
At close: Mar 23, 2026, 4:00 PM EDT
0.1720
+0.0020 (1.18%)
Pre-market: Mar 24, 2026, 7:26 AM EDT

BioAtla Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
8.3249.05111.47215.51244.98238.61
Cash & Short-Term Investments
8.3249.05111.47215.51244.98238.61
Cash Growth
-85.28%-56.00%-48.27%-12.03%2.67%6341.82%
Other Current Assets
1.352.194.944.922.312.08
Total Current Assets
9.6751.23116.41220.43247.29240.68
Net Property, Plant & Equipment
6.081.193.15.156.984.1
Other Long-Term Assets
0.16-0.150.150.150.15
Total Assets
15.9152.42119.66225.74254.42244.94
Accounts Payable
16.8113.726.7221.6118.4212.07
Current Portion of Leases
1.170.841.621.521.39-
Unearned Revenue
-----19.81
Other Current Liabilities
-----0.39
Total Current Liabilities
17.9814.5428.3423.1319.8132.26
Long-Term Debt
-----0.68
Long-Term Leases
5.01-0.842.463.982.02
Other Long-Term Liabilities
24.1523.6219.8119.8119.813.99
Total Long-Term Liabilities
29.1623.6220.6422.2723.796.68
Total Liabilities
47.1538.1648.9945.443.634.96
Common Stock
0.010.010.010.0100
Additional Paid-in Capital
504.62500.3486.93473.14397.14300.89
Retained Earnings
-535.86-486.04-416.26-292.8-186.32-90.92
Total Common Shareholders' Equity
-31.2414.2770.67180.34210.82209.97
Shareholders' Equity
-31.2414.2770.67180.34210.82209.97
Total Liabilities & Equity
15.9152.42119.66225.74254.42244.94
Total Debt
6.180.842.463.985.372.7
Net Cash (Debt)
2.1448.21109.01211.53239.61235.91
Net Cash Growth
-95.56%-55.77%-48.46%-11.72%1.57%-
Net Cash Per Share
0.040.992.285.43--
Book Value
-31.2414.2770.67180.34210.82209.97
Book Value Per Share
-0.550.291.484.63--
Tangible Book Value
-31.2414.2770.67180.34210.82209.97
Tangible Book Value Per Share
-0.550.291.484.63--
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q